An Act relative to testing for Factor V Leiden
Take action
Record your position on this measure.
Create an account to take a stance, submit a written position, or contact your legislator.
Progress
Where this bill stands in the legislative process.
- Introduced
- Passed House
- Passed Senate
- To Governor
- Became Law
Overview
This bill seeks to establish a requirement for genetic testing for Factor V Leiden, a genetic mutation that increases the risk of blood clots. The purpose of this testing is to identify individuals who may be at higher risk of developing venous thromboembolism (VTE), such as deep vein thrombosis and pulmonary embolism. Currently, testing for this condition is not mandated in Massachusetts, and this bill aims to change that. The bill was referred to the Financial Services committee and subsequently concurred by the Senate.
Key provisions
- Requires genetic testing for Factor V Leiden.
- Intended to identify individuals at risk of venous thromboembolism (VTE).
- Addresses potential risks associated with blood clots.
- The bill was referred to the Financial Services committee.
Who is affected
- Individuals seeking healthcare in Massachusetts
- Patients with a family history of blood clots
- Healthcare providers in Massachusetts
Bill text
Read the latest version inline or switch to a previous version.
Text extraction is in progress. View the official source.
Sponsors
Official sponsors from legislative records.
2 on record
Primary sponsor
Daniel J. Ryan
Cosponsor
Daniel J. Ryan
Arguments
Reasons offered for and against this legislation.
Arguments in favor
No arguments in favor have been submitted.
Submit yoursArguments opposed
No arguments opposed have been submitted.
Submit yours